The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation

Shin, Eunju ORCID: https://orcid.org/0000-0002-8865-6834, Lisci, Carlo, Tronci, Elisabetta, Fidalgo, Camino, Stancampiano, Roberto, Björklund, Anders and Carta, Manolo 2014. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of Disease 62 , pp. 233-240. 10.1016/j.nbd.2013.09.021

Full text not available from this repository.

Abstract

Graft-induced dyskinesia (GID) is a serious complication induced by dopamine (DA) cell transplantation in parkinsonian patients. We have recently shown that DA D2 receptor blockade produces striking blockade of dyskinesia induced by amphetamine in grafted 6-OHDA-lesioned rats, a model of GID. This study was designed to investigate whether blockade of DA D1 receptors could produce similar outcome, and to see whether the effect of these treatments in grafted rats was specific for dyskinesia induced by amphetamine, or could also influence L-DOPA-induced dyskinesia (LID). L-DOPA-primed rats received transplants of fetal DA neurons into the DA-denervated striatum. Beginning at 20 weeks after transplantation rats were subjected to pharmacological treatments with either L-DOPA (6 mg/kg) or amphetamine (1.5 mg/kg) alone, or in combination with the D1 receptor antagonist SCH23390, the D2 receptor antagonist eticlopride, and the 5-HT1A agonist/D2 receptor antagonist buspirone. Grafted rats developed severe GID, while LID was reduced. Both eticlopride and SCH23390 produced near-complete suppression of GID already at very low doses (0.015 and 0.1 mg/kg, respectively). Buspirone induced similar suppression at a dose as low as 0.3 mg/kg, which is far lower than the dose known to affect LID in non-grafted dyskinetic rats. In agreement with our previous results, the effect of buspirone was independent from 5-HT1A receptor activation, as it was not counteracted by the selective 5-HT1A antagonist WAY100635, but likely due to D2 receptor blockade. Most interestingly, the same doses of eticlopride, SCH23390 and buspirone were found to suppress LID in grafted but not in control dyskinetic rats. Taken together, these data demonstrate that the DA cell grafts strikingly exacerbate the effect of DA D1 and D2 receptor blockade against both GID and LID, and suggest that the anti-GID effect of buspirone seen in patients may also be due to blockade of DA D2 receptors.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords:	Graft-induced dyskinesia; L-DOPA-induced dyskinesia; Parkinson's disease; Dopamine D1 receptor; Dopamine D2 receptor; Eticlopride; SCH23390; Buspirone; Cell transplantation
Publisher:	Elsevier
ISSN:	0969-9961
Date of Acceptance:	24 September 2013
Last Modified:	31 Oct 2022 09:26
URI:	https://orca.cardiff.ac.uk/id/eprint/81016

Citation Data

Cited 15 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item